These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 13960471)

  • 21. Oral hyoscine butylbromide for irritable bowel syndrome?
    Herxheimer A; Misiewicz JJ
    Br Med J; 1979 Mar; 1(6165):752. PubMed ID: 435770
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral hyoscine butylbromide for irritable bowel syndrome?
    MacRae KD
    Br Med J; 1979 Mar; 1(6165):752. PubMed ID: 435771
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants].
    GADEKE R
    Kinderarztl Prax; 1955 Nov; 23(11):486-92. PubMed ID: 13279076
    [No Abstract]   [Full Text] [Related]  

  • 24. Angioneurotic oedema and urticaria induced by hyoscine butylbromide.
    Robinson AC; Teeling M
    Postgrad Med J; 1982 May; 58(679):316. PubMed ID: 7111123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the value of hyoscine butylbromide and glucagon on aorto iliac intravenous digital subtraction.
    Rowland-Hill CA; Loveday EJ; Thomas ML
    Vasa; 1989; 18(4):301-3. PubMed ID: 2609736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: Hyoscine butylbromide and the oculo-cardiac reflex.
    Fry EN; Hall-Parker BJ
    Br J Ophthalmol; 1975 Sep; 59(9):525. PubMed ID: 1203241
    [No Abstract]   [Full Text] [Related]  

  • 27. Edrophonium-hyoscine butylbromide mixture in neonates.
    Yamashita M; Tajima K
    Anaesthesia; 1989 Feb; 44(2):169. PubMed ID: 2929951
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyoscine-N-butylbromide by intravenous infusion.
    Butler HE; Moody HR
    Med J Aust; 1987 Sep; 147(6):315-6. PubMed ID: 3626960
    [No Abstract]   [Full Text] [Related]  

  • 29. Echocardiographic evaluation of vagolytic effects of hyoscine butylbromide in paediatric halothane anaesthesia.
    Yamashita M; Horigome H
    Agressologie; 1989 Sep; 30(8):489-91. PubMed ID: 2610296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Rebound effect of hyoscine butylbromide on postoperative bowel contractions.
    Fry EN; Deshpande S
    Br Med J; 1976 Mar; 1(6010):646-7. PubMed ID: 1252864
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sonographic study of the effect of hyoscin-N-butylbromide on cholecystokinin stimulated gallbladder motility].
    Wagner T; Botzler R; Ritter U
    Z Gastroenterol; 1984 Jun; 22(6):305-10. PubMed ID: 6464523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide.
    Lowe JR; Hanson LC
    JAMA; 2021 Oct; 326(13):1263-1265. PubMed ID: 34609471
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral hyoscine butylbromide does not alter the pattern of small intestinal motor activity.
    Thompson DG; Wingate DL
    Br J Pharmacol; 1981 Apr; 72(4):685-7. PubMed ID: 7284686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life.
    Abe A; Amano K; Ishiki H
    JAMA; 2022 Jan; 327(3):285. PubMed ID: 35040894
    [No Abstract]   [Full Text] [Related]  

  • 35. Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life-Reply.
    van Esch HJ; van Zuylen L; van der Rijt CCD
    JAMA; 2022 Jan; 327(3):285-286. PubMed ID: 35040890
    [No Abstract]   [Full Text] [Related]  

  • 36. Prophylactic scopolamine butylbromide reduced death rattle in patients in the dying phase.
    Mechineni A
    Ann Intern Med; 2022 Mar; 175(3):JC31. PubMed ID: 35226526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-response relationships of intravenous hyoscine butylbromide and atropine sulphate on heart rate in healthy volunteers.
    Grainger SL; Smith SE
    Br J Clin Pharmacol; 1983 Dec; 16(6):623-6. PubMed ID: 6661345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of imecromone and hyoscine N-butylbromide in endoscopic cholangiopancreatography].
    Garbarini A; Foco A; Serenthà U; Enrichens F; Mao P; Rossetti F
    Minerva Chir; 1986 Jan; 41(1-2):45-50. PubMed ID: 3703309
    [No Abstract]   [Full Text] [Related]  

  • 39. The value of hyoscine butylbromide in aorto-iliac intravenous digital subtraction angiography.
    Bennett C; Phillips GW; Colthurst JR; Lea Thomas M
    Vasa; 1987; 16(3):262-4. PubMed ID: 3310446
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of effectiveness of 4-methylumbelliferone and hyoscine-N-butylbromide in therapy following biliary tract surgery].
    Fischer D; Krumme H
    Med Welt; 1980 Jun; 31(23):894-7. PubMed ID: 6775170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.